trending Market Intelligence /marketintelligence/en/news-insights/trending/jd0IQ-XDJgBZePSZaYCKGg2 content esgSubNav
In This List

Eleven Biotherapeutics receives Nasdaq noncompliance notice

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Eleven Biotherapeutics receives Nasdaq noncompliance notice

Eleven Biotherapeutics Inc. received a notice from the Nasdaq Stock Market LLC for failing to meet the $1 minimum bid price listing requirement.

The company has 180 days or until June 11, 2018, to regain compliance.

To regain compliance, the closing bid price of the company's common stock must meet or exceed $1 per share for a minimum of 10 consecutive business days during the 180-day period.